Paper3984302
'Partial inhibition' of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition.
Giles CM. Vox Sang, 1985. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. 'Partial inhibition' of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition. Papers, record 3984302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3984302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 'Partial inhibition' of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Group Antigens | Major topic |
| Blood Grouping and Crossmatching | Major topic |
| Complement C4 | |
| Humans | |
| Indicators and Reagents |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 3865894 | C4B3 allotype with a novel Ch phenotype. | Immunogenetics | 1985 | https://conductscience.org/library/papers/3865894 | PubMed |
| 3852741 | The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6. | EMBO J | 1985 | https://conductscience.org/library/papers/3852741 | PubMed |
| 3485571 | HLA haplotypes with C4B5; evidence for further allelic heterogeneity. | Immunogenetics | 1986 | https://conductscience.org/library/papers/3485571 | PubMed |
| 2453459 | A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes. | Immunogenetics | 1988 | https://conductscience.org/library/papers/2453459 | PubMed |
| 2444535 | A new antigenic determinant for C4 of relatively low frequency. | Immunogenetics | 1987 | https://conductscience.org/library/papers/2444535 | PubMed |
| 2431902 | Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. | EMBO J | 1986 | https://conductscience.org/library/papers/2431902 | PubMed |
| 2430883 | The purification and properties of some less common allotypes of the fourth component of human complement. | Immunogenetics | 1986 | https://conductscience.org/library/papers/2430883 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3984302
GET https://conductscience.org/api/papers/v1/3984302/authors